Qiao-li B. Lv

Jiangxi Key Laboratory Of Oncology, JXHC Key Laboratory Of Tumour Metastasis
Nanchang, 330029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Epidemiology, Risk Factors, and Routine Blood Biomarkers of Aspergillosis in Cancer Patients in Jiangxi, China.

Epidemiology, Risk Factors, and Routine Blood Biomarkers of Aspergillosis in Cancer Patients in Jiangxi, China.

Journal: Infection and drug resistance

Published: February 25, 2026

Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China.

Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China.

Journal: Microbiology spectrum

Published: August 14, 2025

Epidemiology risk factors and antifungal resistance patterns of Candida in cancer patients in Jiangxi China.

Epidemiology risk factors and antifungal resistance patterns of Candida in cancer patients in Jiangxi China.

Journal: Frontiers in microbiology

Published: May 17, 2025

Invasive Mucormycosis in a Chronic Lymphocytic Leukemia Patient on Zanubrutinib: A Case Report.

Invasive Mucormycosis in a Chronic Lymphocytic Leukemia Patient on Zanubrutinib: A Case Report.

Journal: Infection and drug resistance

Published: March 18, 2025

The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance.

The role of artificial intelligence and machine learning in predicting and combating antimicrobial resistance.

Journal: Computational and structural biotechnology journal

Published: November 11, 2024

The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.

The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.

Journal: Innovation (Cambridge (Mass.))

Published: July 11, 2024

Fungal Influences on Cancer Initiation, Progression, and Response to Treatment.

Fungal Influences on Cancer Initiation, Progression, and Response to Treatment.

Journal: Cancer research

Published: May 14, 2024

Progress of engineered bacteria for tumour therapy.

Progress of engineered bacteria for tumour therapy.

Journal: International immunopharmacology

Published: December 09, 2023

Correction to: Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.

Correction to: Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma.

Journal: Cancer cell international

Published: August 19, 2023

Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas.

Roles of lncRNA-MALAT1 in the Progression and Prognosis of Gliomas.

Journal: Mini reviews in medicinal chemistry

Published: March 30, 2023

CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity.

CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity.

Journal: Cancer letters

Published: January 31, 2023

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus.

Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus.

Journal: The Journal of infection

Published: November 07, 2022

Showing 1-12 of 41

Last Updated: 09/26/2026